IVD Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP2974a
Background:
Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial matrix enzyme that catalyzes the third step in leucine catabolism. The genetic deficiency of IVD results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia.
Other Names:
Isovaleryl-CoA dehydrogenase, mitochondrial, IVD, IVD
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2974a was selected from the N-term region of human IVD. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: IVD (HGNC:6186)
Gene ID: 3712
Primary Accession: P26440
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial matrix enzyme that catalyzes the third step in leucine catabolism. The genetic deficiency of IVD results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia.
Other Names:
Isovaleryl-CoA dehydrogenase, mitochondrial, IVD, IVD
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2974a was selected from the N-term region of human IVD. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: IVD (HGNC:6186)
Gene ID: 3712
Primary Accession: P26440
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review